Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHANTOM Pilot Study: Metformin in Heart Failure and Diabetes
NCT00325910Phase 3Terminated
- Sponsor
- University of Alberta
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), heart failure (HF), sponsored by University of Alberta. Started May 2006; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on NCT00325910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325910.